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Fi.ve large industry federatlons involved in the lndust,rialisat,lon of
blocechnological developuent.s have just presented the European Commlsslon
wlt,h a seE of proposals and recommendat,ions on rules t,o guarant.ee t,he
securlty of modern bloEechnological applicatlons t,haE ls the culmlnation of
a year of working together on thls problem. The federatlons, speakln1 at a
press conference ln Brussels on Aprll 7, annouuced t,he launchlng of a
bl-nonthly English-Ianguage newslet,rer, the EUROPEAN BIOTECHNOLOGY
NEh,SLETTER, that will focus excluslvely on European blotechnology. This
newslet,Eer is being puE out, by the French rnagazine BIOFUTUR wlt,h the
support, of rhe European Comnlsslon.
The Associatlon of l.llcroblal Food Enzyme Producers (AI'IFEP), European Council of
Chenlcal I'lanufact,urers' Federatlons (CEFIC), Confederaialon of the Food and Drink
Industries of the EEC (CIAA), European FederaEion of PharmaceuEical IndusErtesr
Assoclatlons (EFPIA), and Internatlonal Group of Natlonal Assoclatlon of Agrochenical
Il,anufacturers (GIFAP) all took parE in drawing up Ehe recommendatlons slaced for
dlscusslon by the European Coumlssionr6 experEs i.n the comlng weeks. Thls work was
'necessary, according to these lndust,rlal groups, especially slnce a number of fact,ors
currenEly discourage the lndustrlal appllcarlon of blot,echnology ln the EEC, nauely,
the uncompetlElve prlces of raw maEerlals, uncertalnElds concernlng (and someEimes Ehe
lack of) regulatlons, and laws on lnt,ellectual property thaE are nor adapEed to rhe
Prot,ecE1onofbiotechno1ogica1invffiPtion1sthef1e1dofpharmaceutlcals, whlch has made the most, progress ln uslng new Eechnology.
The represent,atlves of the "blg 5" outllned t,he fundamenral ideas that. guided
their work:
- AIl guldellnes or regulatlons must allow for the potential advant,ages in fuEure
Eechnologlcal developments wh1le llulting any inherent risks.
- Ic is nelt,her necessary nor deslrable t.o formulat,e a sj-ngfe seE of guidelines and
rules E,o cover every aspecE of blotechnology. (No furt,her consideraElons have been
felt necessary for areas of blotechnology whlch are either out,side :he scope of
lndust.rial appllcaElons or are adequat,ely covered by exlsting'guidelines and rules.)
- At,tentlon has consequently focused on one area, E,hat, of the planned release lnco che
environment of live organlsms Ehat carry a forelgn gene or gene componenE deliberately
lntegrat,ed lnto their genomes by genetlc englneerlng technology.
- Finally, it, ls considered iuportant Ehat, risk assessBenE of the release ofgent,icalIymodif1edorganismsbedoneonaconD@andbeapp1iedto
allorgan1sat1ons,bot,h1ndustria1andnon-pubI1c,t,hroughout
Ehe EEC (harrnonised rules), and t,hat risk assessrnenc, procedures and their findlngs be
mutally recognlsed.
The French company tBlofutur S.A.r is launching the newsletter on European
blotechnology wlEh the support of the European Cornmlssi-on. The newslet,ter ls almed aE
declslonmakers ln all areas of lndustry or regulat,ory work t,haE are lnfluenced by
blotechnology. AddlElonal inforroatlon may be obt.alned frorn Daniel Bonvalot or Karl
Simpson, EBN/BIOFUTUR,29, rue Buffon, F-75005 Paris (France), Tel.: (33I) 47071L22,
t,elex 2024OO/BL0FUTU F. (Aprll 8, 1986 - European Report) (MZ)
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